MARK MORELAND: Open Payments
NPI 1780220855 · GREENWOOD VILLAGE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 10 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $74 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: APRETUDE, PREVNAR 20, Symbravo, REPATHA, CAPVAXIVE, MOUNJARO, XIFAXAN.
Industry payments across CO — which companies pay providers there.
